Arcturus Therapeutics Holdings Inc. (ARCT) SEC filings
ARCT SEC filings moved a median of -1.69% by the close. ARCT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ARCT overview →
48 measured ARCT SEC filing events.
Where these ARCT SEC filings landedvs 46 measured ARCT SEC filing reactions
| Middle 50% of ARCT SEC filing reactions | -3.83% to +0.99% |
|---|---|
| Median reaction (to close) | -1.69% |
| Measured reactions | 46 |
Point-in-time · zero look-ahead
Half of the 46 ARCT SEC filing events with a measured close landed between -3.83% and +0.99%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Arcturus Therapeutics For: Aug 25 | SEC filing · Form 8-K | +3.48% | +8.66% | |
| Form 10-Q Arcturus Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +1.07% | +13.82% | |
| Form 8-K Arcturus Therapeutics For: Aug 06 | SEC filing · Form 8-K | +1.07% | +13.82% | |
| Form 8-K Arcturus Therapeutics For: Jun 26 | SEC filing · Form 8-K | +7.24% | -0.55% | |
| Form 8-K Arcturus Therapeutics For: Jun 05 | SEC filing · Form 8-K | +0.14% | -3.52% | |
| Form 10-Q Arcturus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -0.36% | +12.16% | |
| Form 8-K Arcturus Therapeutics For: May 01 | SEC filing · Form 8-K | -0.36% | +12.16% | |
| Form DEF 14A Arcturus Therapeutics For: Jun 05 | SEC filing · Form DEF | +1.40% | -3.26% | |
| Form 10-K Arcturus Therapeutics For: Dec 31 | SEC filing · Form 10-K | -6.33% | +0.93% | |
| Form 8-K Arcturus Therapeutics For: Mar 03 | SEC filing · Form 8-K | -6.33% | +0.93% | |
| Form S-3 Arcturus Therapeutics | SEC filing · Form S-3 | +0.66% | +0.49% | |
| Form 8-K Arcturus Therapeutics For: Dec 11 | SEC filing · Form 8-K | +0.95% | -1.63% | |
| Form 10-Q Arcturus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.06% | -5.36% | |
| Form NT 10-Q Arcturus Therapeutics For: Sep 30 | SEC filing · Form NT | +0.06% | -5.36% | |
| Form 8-K Arcturus Therapeutics For: Nov 10 | SEC filing · Form 8-K | +3.89% | -2.03% | |
| Form 8-K Arcturus Therapeutics For: Oct 22 | SEC filing · Form 8-K | -0.61% | +16.57% | |
| Form 8-K Arcturus Therapeutics For: Sep 26 | SEC filing · Form 8-K | +1.75% | +7.88% | |
| Form 8-K Arcturus Therapeutics For: Aug 29 | SEC filing · Form 8-K | +1.00% | -0.12% | |
| Form 10-Q Arcturus Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +3.99% | — | |
| Form 8-K Arcturus Therapeutics For: Aug 11 | SEC filing · Form 8-K | +3.99% | — | |
| Form 8-K Arcturus Therapeutics For: Jun 30 | SEC filing · Form 8-K | -1.31% | -0.23% | |
| Form 8-K Arcturus Therapeutics For: Jun 06 | SEC filing · Form 8-K | -1.03% | -4.28% | |
| Form 10-Q Arcturus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +5.47% | -7.27% | |
| Form 8-K Arcturus Therapeutics For: May 12 | SEC filing · Form 8-K | +5.47% | -7.27% | |
| Form DEF 14A Arcturus Therapeutics For: Jun 06 | SEC filing · Form DEF | +0.89% | -0.70% | |
| Form 10-K Arcturus Therapeutics For: Dec 31 | SEC filing · Form 10-K | +2.42% | -1.69% | |
| Form 8-K Arcturus Therapeutics For: Mar 06 | SEC filing · Form 8-K | +2.42% | -1.69% | |
| Form 10-Q Arcturus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +1.33% | +0.64% | |
| Form 8-K Arcturus Therapeutics For: Nov 07 | SEC filing · Form 8-K | +1.33% | +0.64% | |
| Form 8-K Arcturus Therapeutics For: Aug 13 | SEC filing · Form 8-K | -1.17% | +2.66% | |
| Form 10-Q Arcturus Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -11.28% | |
| Form 8-K Arcturus Therapeutics For: Aug 05 | SEC filing · Form 8-K | +0.00% | -11.28% | |
| Form S-8 Arcturus Therapeutics | SEC filing · Form S-8 | -1.11% | -3.94% | |
| Form 8-K Arcturus Therapeutics For: Jun 19 | SEC filing · Form 8-K | +0.51% | -3.53% | |
| Form 8-K Arcturus Therapeutics For: Jun 14 | SEC filing · Form 8-K | -0.03% | -6.36% | |
| Form 10-Q Arcturus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.84% | -7.88% | |
| Form 8-K Arcturus Therapeutics For: May 08 | SEC filing · Form 8-K | -1.84% | -7.88% | |
| Form DEF 14A Arcturus Therapeutics For: Jun 14 | SEC filing · Form DEF | -0.76% | -3.25% | |
| Form 8-K Arcturus Therapeutics For: Apr 05 | SEC filing · Form 8-K | -0.16% | -3.37% | |
| Form 8-K Arcturus Therapeutics For: Mar 19 | SEC filing · Form 8-K | +1.02% | +3.34% | |
| Form 10-K Arcturus Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.61% | -3.01% | |
| Form 8-K/A Arcturus Therapeutics For: Mar 07 | SEC filing · Form 8-K | +0.61% | -3.01% | |
| Form 8-K Arcturus Therapeutics For: Mar 07 | SEC filing · Form 8-K | +3.21% | +2.42% | |
| Form 8-K Arcturus Therapeutics For: Feb 20 | SEC filing · Form 8-K | +1.42% | +9.44% | |
| Form CT ORDER Arcturus Therapeutics | SEC filing · Form CT | -1.66% | -5.10% | |
| Form 10-Q Arcturus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +5.74% | -2.00% | |
| Form 8-K Arcturus Therapeutics For: Nov 14 | SEC filing · Form 8-K | +5.74% | -2.00% | |
| Form 8-K Arcturus Therapeutics For: Sep 25 | SEC filing · Form 8-K | +2.08% | +1.00% |
Keep exploring
More ARCT: earnings → · analyst actions → · ARCT overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GEMPHIRE THERAPEUTICS INC COMMON (GEMP) | 282 | -1.00% | 30% |
| PRINCIPIA BIOPHARMA INC COMMON (PRNB) | 282 | +0.23% | 59% |
| Aclaris Therapeutics, Inc. (ACRS) | 280 | 0.00% | 48% |
| Anika Therapeutics Inc. (ANIK) | 280 | +0.05% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.